Hormone therapy to reduce levels of estrogen in breast cancer patients, which has long been used for the purposes of tumor reduction prior to surgical extraction, may cause some tumors to mutate and ...

Unopposed estrogen hormone therapy (E-HT) reduces breast cancer risk, while estrogen plus progestin hormone therapy (EP-HT) increases it, especially with long-term use. The study analyzed data from ...

Hormone therapy may be used by young women to relieve symptoms from hormone-­related conditions, menopause, or gynecologic surgery. Use of estrogen hormone therapy was inversely associated with ...

What Is Inluriyo, and Why Does It Matter? Inluriyo (imlunestrant) is a new oral treatment for certain types of locally advanced or metastatic breast cancer that has progressed after at least one round ...

TNBCs rely on fatty acid oxidization (FAO) to fuel tumor growth by breaking down surrounding adipose tissue through lipolysis. Gap junctions, particularly involving GJB3 and connexin 31 (Cx31), ...

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...